Ensign Peak Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,700
| Closed | -$105K | – | 1791 |
|
|
2022
Q3 | $105K | Hold |
14,700
| – | – | ﹤0.01% | 2081 |
|
|
2022
Q2 | $119K | Sell |
14,700
-14,562
| -50% | -$118K | ﹤0.01% | 1928 |
|
|
2022
Q1 | $406K | Sell |
29,262
-43,832
| -60% | -$608K | ﹤0.01% | 1640 |
|
|
2021
Q4 | $2.05M | Sell |
73,094
-9,970
| -12% | -$280K | ﹤0.01% | 942 |
|
|
2021
Q3 | $2.82M | Buy |
83,064
+6,032
| +8% | +$205K | 0.01% | 917 |
|
|
2021
Q2 | $3.15M | Sell |
77,032
-5,711
| -7% | -$233K | 0.01% | 858 |
|
|
2021
Q1 | $3.33M | Sell |
82,743
-12,385
| -13% | -$499K | 0.01% | 814 |
|
|
2020
Q4 | $5.63M | Sell |
95,128
-18,303
| -16% | -$1.08M | 0.01% | 570 |
|
|
2020
Q3 | $5.52M | Buy |
113,431
+52,549
| +86% | +$2.55M | 0.01% | 599 |
|
|
2020
Q2 | $2.95M | Sell |
60,882
-7,599
| -11% | -$368K | 0.01% | 781 |
|
|
2020
Q1 | $1.9M | Buy |
68,481
+60,033
| +711% | +$1.67M | 0.01% | 855 |
|
|
2019
Q4 | $252K | Buy |
+8,448
| New | +$252K | ﹤0.01% | 1609 |
|